Philip Just Larsen

Title: The Innovations of Philip Just Larsen

Introduction

Philip Just Larsen is a notable inventor based in Klampenborg, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of type 2 diabetes. His innovative work has led to the development of a unique patent that showcases his expertise and dedication to improving health outcomes.

Latest Patents

Larsen holds a patent for "Crosslinked polydiallyamine copolymers for the treatment of type 2 diabetes." This patent involves polydiallylamine copolymers, which are copolymers made from monomers of polydiallylamine and either polyvinylamine or polyallylamine. These copolymers are often crosslinked, enhancing their effectiveness. The polydiallyamine copolymers serve as pharmaceutical compositions that can be utilized in treating type 2 diabetes and mitigating its complications. He has 1 patent to his name.

Career Highlights

Philip Just Larsen is associated with Genzyme Corporation, a company known for its focus on developing innovative therapies for serious diseases. His work at Genzyme has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Larsen has collaborated with esteemed colleagues such as Pradeep K Dhal and Robert J Miller. These partnerships have fostered an environment of innovation and have been instrumental in advancing their shared goals in medical research.

Conclusion

Philip Just Larsen's contributions to the field of pharmaceuticals, particularly through his patent on polydiallyamine copolymers, highlight his commitment to addressing critical health issues like type 2 diabetes. His work continues to inspire advancements in medical treatments and showcases the importance of innovation in healthcare.